Oncologix Tech EBITDA vs. Return On Asset
| OCLG Stock | USD 0.0001 0.00 0.00% |
For Oncologix Tech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Oncologix Tech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Oncologix Tech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Oncologix Tech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Oncologix Tech over time as well as its relative position and ranking within its peers.
Oncologix |
Oncologix Tech Return On Asset vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Oncologix Tech's current stock value. Our valuation model uses many indicators to compare Oncologix Tech value to that of its competitors to determine the firm's financial worth. Oncologix Tech is considered to be number one stock in ebitda category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncologix Tech's earnings, one of the primary drivers of an investment's value.Oncologix Return On Asset vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Oncologix Tech |
| = | (572.25 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Oncologix Tech |
| = | -0.12 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Oncologix Return On Asset Comparison
Oncologix Tech is currently under evaluation in return on asset category among its peers.
Oncologix Tech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Oncologix Tech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Oncologix Tech will eventually generate negative long term returns. The profitability progress is the general direction of Oncologix Tech's change in net profit over the period of time. It can combine multiple indicators of Oncologix Tech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana. Oncologix Tech operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 191 people.
Oncologix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Oncologix Tech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Oncologix Tech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Oncologix Tech's important profitability drivers and their relationship over time.
Use Oncologix Tech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oncologix Tech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncologix Tech will appreciate offsetting losses from the drop in the long position's value.Oncologix Tech Pair Trading
Oncologix Tech Pair Trading Analysis
The ability to find closely correlated positions to Oncologix Tech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oncologix Tech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oncologix Tech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oncologix Tech to buy it.
The correlation of Oncologix Tech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oncologix Tech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oncologix Tech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oncologix Tech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Oncologix Tech position
In addition to having Oncologix Tech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Oncologix Pink Sheet
To fully project Oncologix Tech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Oncologix Tech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Oncologix Tech's income statement, its balance sheet, and the statement of cash flows.